Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung disease

BACKGROUND: No results of controlled trials are available for any of the few treatments offered to children with interstitial lung diseases (chILD). We evaluated hydroxychloroquine (HCQ) in a phase 2, prospective, multicentre, 1:1-randomized, double-blind, placebo-controlled, parallel-group/crossove...

Descripción completa

Detalles Bibliográficos
Autores principales: Griese, Matthias, Kappler, Matthias, Stehling, Florian, Schulze, Johannes, Baden, Winfried, Koerner-Rettberg, Cordula, Carlens, Julia, Prenzel, Freerk, Nährlich, Lutz, Thalmeier, Andreas, Sebah, Daniela, Kronfeld, Kai, Rock, Hans, Ruckes, Christian, Wetzke, Martin, Seidl, Elias, Schwerk, Nicolaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308121/
https://www.ncbi.nlm.nih.gov/pubmed/35871071
http://dx.doi.org/10.1186/s13023-022-02399-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308121/
https://www.ncbi.nlm.nih.gov/pubmed/35871071
http://dx.doi.org/10.1186/s13023-022-02399-2

Ejemplares similares